FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912083307> ?p ?o ?g. }

• W2912083307 endingPage "861" @default.
• W2912083307 startingPage "855" @default.
• W2912083307 abstract "Triple-negative breast cancer (TNBC) is one type of the most aggressive breast cancers with poor prognosis. It is of great urgency to develop new therapeutics for treating TNBC. Based on current treatment guideline and genetic information of TNBC, a combinational therapy platform integrating chemotherapy drugs and mRNA encoding tumor suppressor proteins may become an efficacious strategy. In this study, we developed paclitaxel amino lipid (PAL) derived nanoparticles (NPs) to incorporate both chemotherapy drugs and P53 mRNA. The PAL P53 mRNA NPs showed superior properties compared to Abraxane® and Lipusu® used in the clinic including high paclitaxel loading capacity (24 wt.%, calculated by paclitaxel in PAL), PAL encapsulation efficiency (94.7% ± 6.8%) and mRNA encapsulation efficiency (88.7% ± 0.7%). Meanwhile, these NPs displayed synergetic cytotoxicity of paclitaxel and P53 mRNA in cultured TNBC cells. More importantly, we demonstrated in vivo anti-tumor efficacy of PAL P53 mRNA NPs in an orthotopic TNBC mouse model. Overall, these chemotherapy drugs derived mRNA NPs provide a new platform to integrate chemotherapy and personalized medicine using tumor genetic information, and therefore represent a promising approach for TNBC treatment." @default.
• W2912083307 created "2019-02-21" @default.
• W2912083307 creator A5009313898 @default.
• W2912083307 creator A5011060290 @default.
• W2912083307 creator A5026793684 @default.
• W2912083307 creator A5029695887 @default.
• W2912083307 creator A5048063139 @default.
• W2912083307 creator A5050398177 @default.
• W2912083307 creator A5057172349 @default.
• W2912083307 creator A5060305340 @default.
• W2912083307 creator A5060806301 @default.
• W2912083307 creator A5076207787 @default.
• W2912083307 creator A5082738053 @default.
• W2912083307 creator A5089132442 @default.
• W2912083307 date "2019-02-01" @default.
• W2912083307 modified "2023-10-16" @default.
• W2912083307 title "Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer" @default.
• W2912083307 cites W1566258855 @default.
• W2912083307 cites W1935541780 @default.
• W2912083307 cites W1945220000 @default.
• W2912083307 cites W1963706689 @default.
• W2912083307 cites W1971026321 @default.
• W2912083307 cites W1973456512 @default.
• W2912083307 cites W1986939156 @default.
• W2912083307 cites W1992542552 @default.
• W2912083307 cites W1995068068 @default.
• W2912083307 cites W2032543753 @default.
• W2912083307 cites W2039000434 @default.
• W2912083307 cites W2041915312 @default.
• W2912083307 cites W2044702943 @default.
• W2912083307 cites W2051758698 @default.
• W2912083307 cites W2066269784 @default.
• W2912083307 cites W2098270787 @default.
• W2912083307 cites W2103151163 @default.
• W2912083307 cites W2249755146 @default.
• W2912083307 cites W2281088664 @default.
• W2912083307 cites W2402636472 @default.
• W2912083307 cites W2405541722 @default.
• W2912083307 cites W2412158473 @default.
• W2912083307 cites W2547902053 @default.
• W2912083307 cites W2554094503 @default.
• W2912083307 cites W2560367415 @default.
• W2912083307 cites W2560836545 @default.
• W2912083307 cites W2560987571 @default.
• W2912083307 cites W2573033399 @default.
• W2912083307 cites W2582215039 @default.
• W2912083307 cites W2594239688 @default.
• W2912083307 cites W2622319425 @default.
• W2912083307 cites W2726870238 @default.
• W2912083307 cites W2754401101 @default.
• W2912083307 cites W2774223113 @default.
• W2912083307 cites W2796582438 @default.
• W2912083307 cites W2802041199 @default.
• W2912083307 cites W2808558611 @default.
• W2912083307 cites W2888196187 @default.
• W2912083307 cites W2890364568 @default.
• W2912083307 cites W2891634798 @default.
• W2912083307 cites W2898487406 @default.
• W2912083307 doi "https://doi.org/10.1007/s12274-019-2308-9" @default.
• W2912083307 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6858063" @default.
• W2912083307 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31737223" @default.
• W2912083307 hasPublicationYear "2019" @default.
• W2912083307 type Work @default.
• W2912083307 sameAs 2912083307 @default.
• W2912083307 citedByCount "33" @default.
• W2912083307 countsByYear W29120833072019 @default.
• W2912083307 countsByYear W29120833072020 @default.
• W2912083307 countsByYear W29120833072021 @default.
• W2912083307 countsByYear W29120833072022 @default.
• W2912083307 countsByYear W29120833072023 @default.
• W2912083307 crossrefType "journal-article" @default.
• W2912083307 hasAuthorship W2912083307A5009313898 @default.
• W2912083307 hasAuthorship W2912083307A5011060290 @default.
• W2912083307 hasAuthorship W2912083307A5026793684 @default.
• W2912083307 hasAuthorship W2912083307A5029695887 @default.
• W2912083307 hasAuthorship W2912083307A5048063139 @default.
• W2912083307 hasAuthorship W2912083307A5050398177 @default.
• W2912083307 hasAuthorship W2912083307A5057172349 @default.
• W2912083307 hasAuthorship W2912083307A5060305340 @default.
• W2912083307 hasAuthorship W2912083307A5060806301 @default.
• W2912083307 hasAuthorship W2912083307A5076207787 @default.
• W2912083307 hasAuthorship W2912083307A5082738053 @default.
• W2912083307 hasAuthorship W2912083307A5089132442 @default.
• W2912083307 hasBestOaLocation W29120833072 @default.
• W2912083307 hasConcept C104317684 @default.
• W2912083307 hasConcept C105580179 @default.
• W2912083307 hasConcept C121608353 @default.
• W2912083307 hasConcept C126322002 @default.
• W2912083307 hasConcept C150903083 @default.
• W2912083307 hasConcept C179185449 @default.
• W2912083307 hasConcept C185592680 @default.
• W2912083307 hasConcept C207001950 @default.
• W2912083307 hasConcept C2776694085 @default.
• W2912083307 hasConcept C2777292972 @default.
• W2912083307 hasConcept C2780110267 @default.
• W2912083307 hasConcept C502942594 @default.
• W2912083307 hasConcept C530470458 @default.
• W2912083307 hasConcept C55493867 @default.

• next